covid-19 vaccine

One dose COVID-19 vaccine offers solid protection against severe disease

Reading now: 915
www.sciencemag.org

Jon CohenScience's COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation.Less than 24 hours after the small biotech Novavax announced the largely successful results of its COVID-19 vaccine, a vaccine powerhouse, Johnson & Johnson (J&J), said its candidate also had strong efficacy against the pandemic coronavirus, including several new variants that have concerned scientists.

In a press release this morning, the company reported efficacy of 85% in preventing severe cases of COVID-19, including complete protection from hospitalization and death starting 28 days after the dose was given.

Unlike other COVID-19 vaccines with proven protection that were designed to include a booster dose weeks later, J&J bet on.

Read more on sciencemag.org
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA